Cytoo, Cellectis Bioresearch, CEA Receive $10.2M to Develop Cell-based Assays | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French life science firm Cytoo announced today that it, Cellectis Bioresearch, and the French Alternative Energies and Atomic Energy Commission (CEA) are partnering to develop cell-based assays for drug development and toxicology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.